KERI MESSINA: Open Payments
NPI 1154848026 · GREENVALE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,686 in 56 payments from 13 companies in 2025. Trend: 2023 $3,516 · 2024 $1,591 · 2025 $1,686
Food & beverage: $1,686
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 13 | $835 |
| Alnylam Pharmaceuticals Inc. | 18 | $282 |
| AstraZeneca Pharmaceuticals LP | 9 | $176 |
| Actelion Pharmaceuticals US, Inc. | 3 | $72 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $71 |
| SCPHARMACEUTICALS INC. | 2 | $65 |
| ABIOMED | 2 | $49 |
| Galderma Laboratories, L.P. | 1 | $30 |
| Novo Nordisk Inc | 1 | $25 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
Products named: THORATEC HEARTMATE 3 LVAS IMPLANT KIT, AMVUTTRA, CARDIOMEMS, FARXIGA, UPTRAVI, JARDIANCE, FUROSCIX, WAINUA.
Industry payments across NY — which companies pay providers there.
